People with Type 2 diabetes lost up to 60 pounds on Lilly’s latest weight loss drug
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"People with Type 2 diabetes lost up to 60 pounds on Lilly’s latest weight loss drug" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Yahoo, Scientific American, Ars Technica and The Guardian. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 49d ago.
Quick answers
Why is "People with Type 2 diabetes lost up to 60 pounds on Lilly’s latest weight loss d" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (11)
- Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial CNBC · 49d ago
- Experimental weight loss drug yields big results, but not yet FDA approved Yahoo · 49d ago
- Lilly's triple-G allows more than half of patients to drop below obesity line Endpoints News · 49d ago
- Eli Lilly retatrutide sheds 21% body weight in diabetes trial qz.com · 49d ago
- Eli Lilly’s Experimental Weight-Loss Drug Shows Promising Results Time Magazine · 49d ago
- Lilly sets up next-gen obesity battle with full phase 3 retatrutide data fiercebiotech.com · 49d ago
- Lilly's experimental drug cuts weight by 21% in diabetes trial Yahoo · 49d ago
- Blockbuster retatrutide trial signals a ‘new high-water mark’ for weight-loss drugs Scientific American · 49d ago
- Most powerful obesity drug yet: People lost up to 25% of weight in trial Ars Technica · 49d ago
- ‘Godzilla’ of weight-loss drugs could provide other important health benefits The Guardian · 49d ago
- People with Type 2 diabetes lost up to 60 pounds on Lilly’s latest weight loss drug NBC News · 49d ago
Topics
Related trends
Why Are People Acting So Weird in Restaurants?
Restaurant operators across North America are confronting a surge of AI-generated content and shifting diner behavior that is upending daily service.
Sombr Chips Tooth During Wisconsin Concert, On Video
Sombr chips a tooth for the fourth time during a Wisconsin concert, captured on video.
Why Did So Many People File Early for Social Security Last Year?
A surge in early Social Security filings is sparking a debate over the long-term financial costs of claiming benefits at age 62 versus waiting until 67 or 70.
Emma Roberts wishes aunt Julia Roberts a happy birthday with heartwarming family snapshot
Entertainment outlets cover birthday tributes paid to actress Julia Roberts by family members including Emma Roberts and Danny Moder.
People’s New Sexiest Man Alive Is Proving Weirdly Controversial
Noah Wyle has been crowned People magazine's 2026 Sexiest Man Alive, sparking immediate debate across digital media.
Former Disney star Christy Carlson Romano thought she was 'going to die' after freak shooting accident
Former Disney star Christy Carlson Romano reveals the lasting impact of a near-fatal shotgun accident that left her fearing for her life and her sight.